STAT+: Why doctors and patients are having two totally different AI chatbot experiences
Stat News • 2/11/2026
Summary
In this edition of STAT's AI Prognosis, Brittany Trang discusses the differing experiences of doctors and patients with AI chatbots. The performance of AI models varies by user, which can lead to dangerous outcomes.
Advertisement
Lindy Score Breakdown (V4.2)
52d
Age
1
Sources
from cluster
1258
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1258/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1258/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 52 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 2 days ago
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Stat News • 2 days ago
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 2 days ago
STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Stat News • 2 days ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 2 days ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 2 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 1 day ago
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • 2 days ago
STAT+: Up and down the ladder: The latest comings and goings
Stat News • 1 day ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 3 days ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago